Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progranulin: A key player in autoimmune diseases.
Prothrombin and factor X are elevated in multiple sclerosis patients.
SYSTEMIC TRANSPLANTATION OF BONE MARROW MONONUCLEAR CELLS PROMOTES AXONAL REGENERATION AND ANALGESIA IN A MODEL OF WALLERIAN DEGENERATION.
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
Bone And Soft Tissue Changes In Patients With Spinal Cord Injury And Multiple Sclerosis.
Brain stiffness increases with myelin content.
Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome.
Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1.
High-resolution three-dimensional macromolecular proton fraction mapping for quantitative neuroanatomical imaging of the rodent brain in ultra-high magnetic fields.
Immunology of neuromyelitis optica during pregnancy.
AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
[Evaluation of repetitive transcranial magnetic stimulation effectiveness in treatment of psychiatric and neurologic diseases].
Mast cells: New therapeutic target in helminth immune modulation.
Beta interferon decision is 'disappointing'.
Visual impairment.
Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis.
Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes.
Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation.
Thalamocortical-auditory network alterations following cuprizone-induced demyelination.
Normonatremic osmotic demyelination in the setting of acquired immune deficiency syndrome and malnutrition: case report and literature review.
Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis.
Mapping face encoding using functional MRI in multiple sclerosis across disease phenotypes.
Zinc transporter 3 (ZnT3) gene deletion reduces spinal cord white matter damage and motor deficits in a murine MOG-induced multiple sclerosis model.
Pages
« first
‹ previous
…
756
757
758
759
760
761
762
763
764
…
next ›
last »